S.B. 2915 Summary

• Adds three new definitions to Hawaii's controlled substances law: "pharmacy delegate," "practitioner delegate," and "reverse distributor" to clarify roles of individuals accessing the electronic prescription accountability system and those handling controlled substance returns.

• Adds acetyl fentanyl to Schedule I opiates and MAB-CHMINACA to Schedule I cannabinoids, and adds eluxadoline to Schedule IV substances to align with federal drug scheduling.

• Requires all practitioners (except veterinarians) and pharmacies to register with the electronic prescription accountability system when obtaining controlled substance registration.

• Establishes that reverse distributors must register with the Department of Public Safety and limits Schedule II narcotic prescriptions to 30-day supplies except for single-unit dose packages or terminally ill patients.

• Eliminates the requirement for a pseudoephedrine permit when transporting more than three packages of pseudoephedrine-containing products and allows the Department of Public Safety to post drug schedule updates on its website instead of republishing them.